GlassScriptPhysician profile
Henry C Mostellar
NPI 1578677928
$261.43
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.32 · 2020: $81.46 · 2021: $88.98 · 2022: $32.67.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $68.01 | 2019-2020 | |
| Baudax Bio INC. | $35.24 | 2020-2021 | |
| Lsi Solutions INC | $19.43 | 2022 | |
| Baxter Healthcare | $16.41 | 2021 | |
| Axonics, INC. | $15.99 | 2021 | |
| Hologic INC | $15.47 | 2020 | |
| Avanos Medical | $14.42 | 2021 | |
| Nestle Healthcare Nutrition INC. | $13.72 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.24 | 2022 | |
| Medtronic USA, INC. | $13.06 | 2019 | |
| Innocoll Pharmaceuticals Limited | $12.74 | 2021 | |
| Tela Bio, INC. | $12.73 | 2020 | |
| Tetraphase Pharmaceuticals, INC. | $10.97 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Mostellar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.